PT-2023-14719 · Fresenius Kabi · Fresenius Kabi Pharmahelp

Published 2023-08-22 · Updated 2024-01-10 · CVE-2022-45611

Positive Technologies (AI Summary)

CVSS v3.1

9.8

Critical

Base vector

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Name of the Vulnerable Software and Affected Versions Fresenius Kabi PharmaHelp version 5.1.759.0

Description An issue was discovered that allows attackers to gain escalated privileges via capture of user login information.

Recommendations For Fresenius Kabi PharmaHelp version 5.1.759.0, consider restricting access to sensitive features until a patch is available to prevent attackers from capturing user login information and gaining escalated privileges. At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Insufficiently Protected Credentials

Weakness Enumeration

CWE-522

Related Identifiers

CVE-2022-45611

Affected Products

Fresenius Kabi Pharmahelp

References · 7

• https://osv.dev/vulnerability/CVE-2022-45611 · Vendor Advisory
• https://nvd.nist.gov/vuln/detail/CVE-2022-45611 · Security Note
• https://fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf · Note
• https://fresenius-kabi.com/de-at/produkte/pharmahelp-compounder · Note
• https://t.me/cvenotify/66859 · Telegram Post
• https://fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf · Note
• https://t.me/cibsecurity/69026 · Telegram Post